AstraZeneca (AZN) Announces FDA Updated SYMBICORT Label with LABA Safety Class Revisions and Removed Boxed WARNING for Serious Asthma-Related Outcomes
Tweet Send to a Friend
AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved updates to the SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
